Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia B, Congenital”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05568459
What this trial is testing

A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy

Who this might be right for
Hemophilia B
Regeneron Pharmaceuticals 11
Early research (Phase 1)Study completedNCT01561417
What this trial is testing

Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects

Who this might be right for
Acquired Bleeding DisorderAcquired HaemophiliaCongenital Bleeding Disorder+5 more
Novo Nordisk A/S 28
Large-scale testing (Phase 3)Ended earlyNCT05695391
What this trial is testing

Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major Surgery

Who this might be right for
Hemophilia
Laboratoire français de Fractionnement et de Biotechnologies 2
Post-approval studies (Phase 4)Study completedNCT01128881
What this trial is testing

IMMUNINE Pre-Treatment Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 57
Early research (Phase 1)Study completedNCT03186677
What this trial is testing

Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients

Who this might be right for
Hemophilia B
ISU Abxis Co., Ltd. 11
Large-scale testing (Phase 3)Looking for participantsNCT04563520
What this trial is testing

SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis

Who this might be right for
Hemophilia A
Emory University 5
Not applicableUnknownNCT03533504
What this trial is testing

Web Accessible Population Pharmacokinetics Service - Hemophilia: Sources of Variability

Who this might be right for
Hemophilia AHemophilia B
McMaster University 1,000
Testing effectiveness (Phase 2)Study completedNCT01361126
What this trial is testing

A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 17
Large-scale testing (Phase 3)Study completedNCT02548143
What this trial is testing

LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures

Who this might be right for
Hemophilia
Laboratoire français de Fractionnement et de Biotechnologies 12
Large-scale testing (Phase 3)Study completedNCT00868530
What this trial is testing

Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects

Who this might be right for
Hemophilia A
Pfizer 53
Not applicableLooking for participantsNCT03327779
What this trial is testing

World Bleeding Disorders Registry

Who this might be right for
Hemophilia AHemophilia BVon Willebrand Diseases
World Federation of Hemophilia 20,000
Testing effectiveness (Phase 2)Study completedNCT04073498
What this trial is testing

The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)

Who this might be right for
Hemophilia aHemophilia B
ApcinteX Ltd 39
Testing effectiveness (Phase 2)Study completedNCT00108758
What this trial is testing

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 23
Post-approval studies (Phase 4)Study completedNCT00002386
What this trial is testing

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
Merck Sharp & Dohme LLC 55
Large-scale testing (Phase 3)Study completedNCT03569891
What this trial is testing

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Who this might be right for
Hemophilia B
CSL Behring 67
Early research (Phase 1)WithdrawnNCT02084810
What this trial is testing

Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia A With Inhibitors+3 more
Novo Nordisk A/S
Not applicableStudy completedNCT03619863
What this trial is testing

ATHN 7: Hemophilia Natural History Study

Who this might be right for
Hemophilia A With InhibitorHaemophilia A Without InhibitorHemophilia B With Inhibitor+1 more
American Thrombosis and Hemostasis Network 395
Not applicableStudy completedNCT02922231
What this trial is testing

Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South Korea

Who this might be right for
Hemophilia B
Baxalta now part of Shire 57
Post-approval studies (Phase 4)Study completedNCT00108797
What this trial is testing

Trial of NovoSeven® in Haemophilia - Joint Bleeds

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 42
Large-scale testing (Phase 3)Study completedNCT00093210
What this trial is testing

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer
Next Page